Publikationen, an denen er mitarbeitet Ana Martínez Gil (2)

2025

  1. Glycogen Synthase Kinase-3β Inhibitor VP3.15 Ameliorates Neurogenesis, Neuronal Loss and Cognitive Impairment in a Model of Germinal Matrix-intraventricular Hemorrhage of the Preterm Newborn

    Translational Stroke Research, Vol. 16, Núm. 2, pp. 467-483

2024

  1. VP3.15 reduces acute cerebellum damage after germinal matrix-intraventricular hemorrhage of the preterm newborn

    Biomedicine and Pharmacotherapy, Vol. 180